All gene segments of influenza virus share a common feature at their respective termini. Both the 5h-and 3h-terminal sequences are highly conserved and possess partial inverted complementarity. This allows for the formation of a double-stranded duplex, which plays a major role in transcription, replication and packaging of the viral genome. In vitro studies have shown that the viral polymerase binds to short RNA molecules containing these termini. In this study, attempts were made to test whether mini-RNA decoys containing either or both termini can inhibit the activity of the viral polymerase in vivo. RNA molecules containing either the 5h or the 3h noncoding sequences were unable to inhibit NS-CAT RNA replication, while mini-RNA decoys consisting of both the 5h and 3h noncoding sequences of vRNA or cRNA were able to efficiently inhibit the activity of the viral polymerases expressed from vaccinia virus vectors.
The genome of influenza A virus consists of eight singlestranded RNA segments of negative polarity. Sequence analyses of each RNA segment of the influenza A virus genome revealed a short conserved noncoding sequence at both the 5h and 3h termini (Skehel & Hay, 1978 ; Robertson, 1979 ; Desselberger et al., 1980) . The first 13 nucleotides at the 5h terminus are identical among all eight gene segments, while the first 12 nucleotides at the 3h terminus exhibit variation at only one position. In addition, the sequences at the 5h and 3h termini possess partial inverted complementarity that could allow an RNA duplex to form. The existence of such an RNA duplex was experimentally demonstrated in vivo (Hsu et al., 1987) . Further work has demonstrated that the structure and\or sequence of these termini function as cis-acting signals for transcription, replication and assembly of the viral genome (Luytjes et al., 1989 ; Luo et al, 1991 ; Luo & Palese, 1992 ; Li & Author for correspondence : Guangxiang Luo.
Fax j1 203 284 6088. e-mail GuangxiangILuo#ccmail.bms.com Piccone et al., 1993 ; Hagen et al., 1994 ; Fodor et al., 1994) . This was made possible through the in vitro reconstitution of ribonucleoprotein (RNP) using viral polymerase (PB1, PB2 and PA) proteins and nucleoprotein (NP) purified from virions, together with in vitro cDNA-derived RNAs . Genetic analyses of the panhandle structure in vivo revealed that the RNA duplex, along with a juxtaposed stretch of uridines about 17-22 nucleotides from the 5h terminus, is needed for poly(A) addition of the viral mRNA (Luo et al., 1991) . Interestingly, it was later suggested that this RNA duplex was also involved in the initiation of in vitro transcription of short model RNAs Fodor et al., 1994) . Besides functioning as cis-acting signals for transcription and replication, the 5h-and 3h-terminal sequences have been found to be required for differential activation of the viral polymerase complex (PB1, PB2 and PA) activities Cianci et al., 1995) .
On the other hand, most of our knowledge about the trans elements required for transcription and replication of the viral genome has been derived through genetic analyses of the viral RNAs synthesized in vivo and from studies using extracts prepared from wild-type and mutant virus-infected cells (Krug et al., 1989) . The recent development of an influenza virus-free replication system using recombinant vaccinia virus vectors has facilitated our understanding of the trans functions required for virus replication (Huang et al., 1990) . Using the recombinant vaccinia virus expression system, it was found that the viral polymerase complex composed of PB1, PB2 and PA proteins is inactive until it specifically binds to the 5h and 3h termini of either vRNA or cRNA Tiley et al., 1994 ; Cianci et al., 1995) .
These studies lead to the assumption that RNAs containing the conserved termini of influenza virus may be efficient inhibitors of viral replication in vivo, through sequestering of viral polymerase. This hypothesis was examined through the use of an in vivo RNA expression system (Pattnaik et al., 1992) . Firstly, DNA vectors were constructed from which RNA molecules with precise 5h and 3h ends of influenza virus genome could be produced, as these are required for full recognition of the RNA template by the viral polymerase complex (Li & Palese, 1992 ; Piccone et al., 1993 ; Tiley et al., 0001-4710 # 1997 SGM CDCJ Fig. 1 . Expression clones for the NS-CAT reporter plasmid (Luytjes et al., 1989) and decoy RNAs. RNA transcription is driven by a T7 promoter and terminated by a T7 termination signal sequence (Pattnaik et al., 1992) , while the 3h end of the RNA is processed by the transcribed HDV genomic ribozyme (Perrotta & Been, 1991) . The sequences of the minimal viral RNA decoys are shown. The extra nucleotides introduced into the NS-C5h and NS-C3h RNAs are underlined. The complementary sequences added in the NS-C5h and NS-C3h RNAs are indicated in italic.
1994) (Fig. 1) . The 5h end of the RNA molecule initiates through the use of a T7 promoter, while the 3h end of the transcript is created through autocatalytic processing by the genomic ribozyme of hepatitis delta virus (HDV) (Perrotta & Been, 1991) . A T7 termination signal sequence is placed downstream of the HDV ribozyme to eliminate further transcription by the T7 RNA polymerase. The construct, NS-CAT, was designed to express a functional vRNA encoding chloramphenicol acetyltransferase (Luytjes et al., 1989) . Four additional DNA constructs expressed short RNAs containing either the 5h or 3h terminus of vRNA or cRNA, while two other clones expressed both termini of minus sense (NS-V5h-3h) or plus sense (NS-C5h-3h) viral RNA (Fig. 1) . The expression of authentic NS-CAT RNA was initially examined in vitro after T7 transcription. Most of the RNA transcripts terminated at the engineered T7 terminator, with more than 70 % of the transcripts processed by the genomic HDV ribozyme to produce RNA of the correct size (data not shown). The authenticity of the NS-CAT RNA generated from this DNA vector was then validated in vivo (Fig. 2 ) using viral polymerases expressed from vaccinia virus vectors (Huang et al., 1990) . Only if the 5h and 3h end sequences were precise would viral polymerase efficiently replicate and transcribe the NS-CAT RNA in vivo. 293 Cells were first infected with recombinant vaccinia viruses individually expressing PB1, PB2, PA, NP and T7 RNA polymerase proteins. At 30 min postinfection, the NS-CAT DNA was transfected into cells using lipofectin. At 16-18 h post-transfection, cells were harvested and lysed three times by freeze-thawing. The level of protein expression was determined by CAT assays (Luytjes et al., 1989) . As observed in Fig. 2 , CAT activity is expressed in vivo from the transfected DNA, and is dependent on the expression of all viral polymerase proteins and the NP protein.
The level of CAT expression using the DNA vector producing NS-CAT RNA was then used to monitor the activity of the viral polymerases in the presence of the minimal RNA decoys (Fig. 1) . 293 Cells were first co-infected with five recombinant vaccinia viruses expressing the three viral polymerases, NP and T7 RNA polymerase. Subsequently, these cells were lipofectin-transfected with 0n5 µg of pNS-CAT DNA plus 2n5 µg of either NS-V5h, NS-V3h or NS-V5h-3h, which produce 5h, 3h or 5h and 3h noncoding sequences of the NS gene, respectively (Fig. 1) . To correct for DNA concentrations, the total amount of DNA transfected into each dish of 293 cells was kept constant by the addition of the parental pUC19\RT vector. At 16-18 h post-transfection, cells were collected and the level of CAT expression was determined. Expression of mini-RNA containing either the 5h or 3h ends of vRNA had no significant effect on the expression of functional CAT enzyme. However, the mini-RNA genome containing both 5h and 3h noncoding sequences of the NS vRNA was able to inhibit most of the CAT expression (Fig. 3 A) . This is presumably due to the sequestering of viral polymerase through binding to the decoy RNA. Interestingly, the viral polymerase activity was not affected even if the DNAs expressing RNAs with the 5h or 3h noncoding sequences were co-transfected together (Fig. 3 A) . This differs from in vitro experiments, which showed that the endonuclease activity of viral polymerase could be rescued through the addition of 5h and 3h ends from single or separate RNAs . To examine the potency of the NS-V5h-3h RNA plasmid DNA CDDA RNA inhibitors of influenza viral polymerases RNA inhibitors of influenza viral polymerases 2 dishes were transfected with 0n5 µg of NS-CAT DNA and 2n5 µg of either NS-V5h, NS-V3h, NS-V5h and NS-V3h, or NS-V5h-3h DNA, as indicated by (j). pUC19/RT vector DNA was added to keep the total amount of DNA transfected constant for each was titrated, keeping the total DNA concentration constant. As shown in Fig. 3 (B) , the inhibitory activity of this mini-RNA genome consisting of only 5h and 3h noncoding sequences of the NS gene is concentration-dependent. By adding equal amounts of NS-CAT and NS-V5h-3h DNA (approximately 1:1n2 molar ratio) the level of CAT expression was inhibited by 80 % compared to the control (Fig. 3 B) .
As the termini of vRNA were able to inhibit CAT expression, the system was then used to evaluate the cRNA sense mini-RNA decoys for their inhibitory activity. The RNA sequence of the mini-cRNA decoy is exactly complementary to that of the mini-vRNA decoy. However, the mini-RNAs containing either 5h or 3h noncoding sequences of the NS cRNA were engineered to be slightly longer than their vRNA counterparts. The length of the NS-C5h or NS-C3h RNA (Fig.  1) was extended beyond the noncoding region by the addition of extra nucleotides in order to match the size of the minicRNA NS-C5h-3h. In addition, the nucleotides (Fig. 1 , underlined) introduced into the NS-C5h and NS-C3h RNAs in order to increase the length were also engineered to be complementary to each other, to enable a more stable RNA duplex structure to be formed when the two RNAs are co-expressed. The results derived from the experiments on these RNAs are shown in Fig. 3 (C, D) . The observations are the same as those obtained from vRNA sense mini-RNA. Only the mini-cRNA decoy has potent inhibitory activity against the viral polymerase (Fig. 3 C) . Neither the constructs expressing one of the termini, nor the co-expression of NS-C5h and NS-C3h RNAs, significantly inhibited viral polymerase activity. In addition, the inhibitory activity of NS-C5h-3h RNA is also proportional to the amount of transfected DNA (Fig. 3 D) . It appears that the cRNA sense NS-C5h-3h RNA has about five to ten times better inhibitory activity than that of the vRNA sense NS-V5h-3h RNA (Fig. 3 B, D) . At this time, it is not known why the cRNA termini are better inhibitors than vRNA termini. It was previously reported that the copy number of vRNA is much greater than that of cRNA in the virus-infected cell (Mukaigawa et al., 1991) . Therefore, it could be that the promoter in the cRNA decoy is stronger than that in the transfection. At 16-18 h post-transfection, cells were harvested and lysed, and one tenth of each cell extract was used for CAT assay, as described previously by Luytjes et al. (1989) . ( vRNA decoy, and it would sequester the polymerase with greater efficiency. Also, if the viral polymerase can replicate the decoy RNAs, a better promoter in vivo would produce more progeny decoys.
The results described in this study suggest that the mini-RNA decoys containing both 5h and 3h noncoding sequences of either vRNA or cRNA of influenza virus genome can be competitive inhibitors of the viral polymerases in vivo. Presumably, this is due to the ability of the decoys to bind to and sequester polymerase. An alternative mechanism of inhibition is that these decoy RNAs are acting as antisense molecules and binding to the NS-CAT replicative RNAs. It is unlikely that this is a significant factor in the inhibition, as the RNAs expressing only one terminus do not exhibit inhibitory effects on viral polymerase-dependent CAT activity (Fig. 3 C) . The inhibition described for the panhandle decoy RNA is directed against an in vivo recombinant replication\ transcription system. It is not known whether these mini-RNA decoys would be active against influenza virus growth in vivo. It is not feasible to use this vaccinia virus-based expression system in this context, as vaccinia virus infection by itself depresses influenza virus growth (unpublished observations). Alternative expression systems are required to address this question.
These in vivo studies differ from published in vitro analyses in one regard. In vitro, polymerase has been shown to bind tightly to the isolated 5h sequences and less avidly to isolated 3h end sequences (Tiley et al., 1994 ; Fodor et al., 1993) . In fact, binding to the 5h end sequence in vitro could prevent polymerase from binding to the duplex RNA consisting of both 5h and 3h ends (Tiley et al., 1994) . Polymerase has even been shown to bind to 5h end sequences in the context of mRNA, where this sequence is offset from the end by 9-15 bases of host sequence (Shih et al., 1995) . However, the miniRNAs containing either 5h or 3h noncoding sequences alone did not inhibit the viral polymerase activity in vivo. The reason for this is not yet known. One possible explanation may be that the level of RNA containing either 5h-or 3h-terminal sequences, which is transcribed from T7 polymerase, is not high enough to compete out binding by the viral polymerase, as the level of RNA decoy determines its activity in vivo (Sullenger et al., 1990) . However, the mini-vRNA and -cRNA decoys may be replicated by the viral polymerase complex as they contain all the viral sequences necessary for replication (Luytjes et al., 1989 ; Huang et al., 1991) , thereby amplifying their inhibitory activity. In this regard, they may be working through a mechanism similar to that thought to be used by defective-interfering RNAs (Nayak et al., 1989) . Further studies are needed to illustrate their mechanism of action and to determine whether these molecules can be developed as possible antiviral agents.
